SECsense Logo

Sonnet Biotherapeutics 8-K Report: Key Insights and Filing Details

$SONN
Form 8-K
Filed on: 2025-02-13
Source
Sonnet Biotherapeutics 8-K Report: Key Insights and Filing Details

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Sonnet Biotherapeutics Holdings, Inc.
  • CIK (Central Index Key): 0001106838
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-35570
  • EIN (Employer Identification Number): 20-2932652
  1. Address:
  • Location: 100 Overlook Center, Suite 102, Princeton, NJ 08540
  • Contact Number: (609) 375-2227
  1. Filing Details:
  • Form Type: 8-K (Current Report)
  • Filing Date: February 13, 2025
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.0001
  • Ticker Symbol: SONN
  • Exchange: NASDAQ
  1. Reporting Period:
  • As of Date: February 13, 2025
  1. Units of Measurement:
  • Currency: USD (U.S. Dollar)
  • Shares: The report references shares but does not provide specific numerical data in this excerpt.

Insights:

  • The filing is a current report (8-K), which typically indicates that the company is reporting significant events or changes that shareholders should know about.
  • The fact that the stock is listed on NASDAQ suggests that the company is subject to stringent regulatory requirements and is seeking to maintain transparency with its investors.
  • The use of XML and XBRL indicates that the company is leveraging modern technology for financial reporting, which may enhance the accuracy and accessibility of its financial data.

Overall, this section provides essential information about the company’s identity, its stock details, and the nature of the filing, which are crucial for investors and analysts monitoring the company's performance and compliance.